Search

Medicamen Biotech

Sector: Healthcare | Industry: Drugs & Pharma
R 345.75 -9.15  | -2.58% -18.71% 34.95 422.39
BSE Price: Oct 18, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 18, 2019 345.75 -9.15 -2.58% 328.05 354.90 10,272 328.00 - 363.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 3,392 P/B: 3.69 NSE Code:
52-Week Range: R 306.00 - 555.95 Dividend Yield: 0.29% BSE Code: 531146
TTM EPS: R 9.89 Book Value: R 93.77 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Medicamen Biotech -20.22 -2.66 -16.21 -18.67 6.98 - 34.42
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 9.95 22.15 10.85
Net Profit 18.92 192.43 163.77
EPS 18.92 177.46 149.79
Book Value 15.72 60.21 32.18
Average
Operating Margin 17.23 16.13 13.11
Net Margin 9.52 8.23 5.19
Return on Networth 14.96 19.53 12.80
Return on Investment 20.22 23.08 18.43
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.44 -4.99 -6.44
Operating Profit 3.04 -6.01 3.04
Net Profit 15.57 1.83 15.57
EPS 15.57 1.83 15.57
TTM
Revenue -1.33 2.29 -1.33
Operating Profit -1.56 5.13 -1.56
Net Profit 0.49 13.98 0.49
EPS 0.49 11.52 0.49
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Medicamen Biotech 422.39 120.97 12.09 9.79 14.96 3.69 34.95
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 21, 2019 SHIVALIK RASAYAN LTD  Buy Allotment 260,000 502.10 1,305.46
Mar 06, 2018 Shivalik Rasayan Ltd  Buy Preferential Offer 76,000 703.20 534.43
Nov 01, 2017 Growel Capital Services Pvt Ltd  Buy Conversion of Warrants 40,000 613.45 245.38
Nov 01, 2017 Rajesh Madan  Buy Conversion of Warrants 20,000 613.45 122.69
Nov 01, 2017 Shivalik Rasayan Ltd  Buy Conversion of Warrants 80,000 613.45 490.76
News & Announcements
Contact Information

Company: Medicamen Biotech Ltd.

Address: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, Delhi - 110019 | Phone: 011-47589500 | Fax: 011-26213081

Email: [email protected]

Website: www.medicamen.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Noble Heights, 1st Floor, Plot NH 2C-1 Block LSC, Near Savitri MarketJanakpuriNew Delhi-11005891-4141-0592/93/9491-4141-0591, Noble Heights, 1st Floor, Plot NH 2, C-1 Block LSC, Near Savitri Market, Janakpuri | Phone: 91-4141-0592/93/94 | Fax: 91-4141-0591

Essential checks
Altman Z-Score
7.58
Piotroski F-Score
5
Modified C-Score
5
5-Years Price to Earnings
34.95
5-Years Price to Book
3.69
Earnings Yield
EBIT / Enterprise value
4.24%
PEG
Price / Earnings to growth ratio
0.18
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59